Parenteral Nutrition Market Players, Size and Share by 2030

Parenteral Nutrition Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis By Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins and Minerals) and End User (Hospitals, Clinics, and Others)

Publication Month : Feb 2024

  • Report Code : TIPRE00005217
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 154
Inquire Before Buy

PRICING

$5190

$4152

[Research Report] The parenteral nutrition market size was valued at US$ 6.84 billion in 2022 and is projected to reach US$ 11.12 billion by 2030; the market is estimated to record a CAGR of 6.0% from 2022 to 2030.

Market Insights and Analyst View:

Parenteral nutrition is a type of nutritional supplementation administered intravenously that includes fluids, vitamins, minerals, trace elements, amino acids, and electrolytes. Compared to enteral (gastric or intestinal) feeding, parenteral nutrition is more complex, more costly, and linked to a higher risk of infection and longer hospital stays. Only patients who are unable to receive nutrition enterally are prescribed parenteral nutrition. The goals of parenteral nutrition therapy include restoring nutritional status, treating hypoproteinemia, fixing muscle weakness, and replacing other nutritional deficits. Factors such as the rise in the prevalence of gastrointestinal diseases and the surge in cases of malnutrition and premature births propel the parenteral nutrition market growth.

Growth Drivers and Challenge:

Crohn’s disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and gastric cancer are a few examples of gastrointestinal diseases. According to the “Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study,” published in January 2021, functional gastrointestinal disorders have affected over 40% of people across the globe. Based on the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019. China (911,405) and the US (762,890) registered the highest number of cases, with prevalence of 66.9 and 245.3 cases per 100,000 people, respectively. Ulcerative colitis and Crohn’s disease are two of the commonly diagnosed IBDs. Crohn’s disease is a complex, chronic disorder that primarily affects the digestive system. It is the most common disease in North America and Europe. Research conducted by Crohn’s & Colitis UK shows that ~1 in every 123 people in the UK had either Crohn’s disease or ulcerative colitis in 2022, accounting for approximately 0.5 million people suffering from IBD in the UK. Moreover, short bowel syndrome (SBS) occurs in ~3 per 1 million people yearly. As per the article titled “Understanding Short Bowel Syndrome: Current Status and Future Perspectives," published in 2020, the prevalence of short bowel syndrome (SBS) has increased by more than twofold in the last 40 years. The prevalence was ~30 cases per million in the US and approximately 1.4 cases per million in Europe.

Patients suffering from gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They might also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirements, which can be a result of the disease itself. Hence, medical nutrition is recommended for gastrointestinal disease patients as they are unable to ingest food. Further, the parenteral routes are preferred to provide them with essential nutrients. Some people might not show compatibility with tube insertion, which makes meeting their calorie and nutrient needs difficult. In such cases, parenteral nutrition is preferred to ensure their bodies remain hydrated and meet the calorie and other nutrient intake required to maintain physical well-being and function. Parenteral nutrition is indicated when patients cannot meet their nutritional needs as they are diagnosed with diseases such as cancer and chronic diseases, which affect the gastrointestinal tract. This type of nutrition is highly preferred as a therapy option for most patients suffering from severe SBS. Therefore, the growing prevalence of gastrointestinal diseases drives the parenteral nutrition market growth.

Innovation in formulations of nutrition products is expected to bring new parenteral nutrition markettrends in the coming years. However, major concerns related to parenteral nutrition include infection of the bloodstream and IV catheter. The infection of the bloodstream is mainly due to the atrophy of the digestive tract when it is not in use. Complications associated with catheter placement comprise infection, occlusion, central venous thrombosis (CVT), pulmonary embolism (PE), and breakage. Blood vessel thrombosis (blood clot formation) around an IV catheter is another potential complication with IV therapy and IV nutrition. Catheter occlusion can be a result of mechanical obstruction, IV fat solutions, or precipitates. Other complications associated with parenteral nutrition include hyperglycemia and hypertriglyceridemia, which affects a large patient population worldwide. Receiving dextrose in excessive quantities (due to overfeeding) or receiving a rapid infusion of IV lipids results in hypertriglyceridemia. Thus, the complications associated with parenteral nutrition that might result in mortality and limitations related to catheter placement hinder the parenteral nutrition market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Parenteral Nutrition Market: Strategic Insights

parenteral-nutrition-market
Market Size Value inUS$ 6.84 billion in 2022
Market Size Value byUS$ 11.12 billion by 2030
Growth rateCAGR of 6.0% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The “parenteral nutrition market analysis” has been carried out by considering the following segments:  nutrient type and end user. By nutrient type, the market is segmented into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. Based on end user, the market is categorized into hospitals, clinics, and others.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

 

Segmental Analysis:

The parenteral nutrition market, by nutrient type, is segmented into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamins and minerals. In 2022, the single dose amino acid solution segment dominated the parenteral nutrition market share; and the parenteral lipid emulsion segment is likely to register the highest CAGR during the forecast period. There is a growing need for nutrition therapies such as parenteral amino acids that deliver a substantial amount of protein, but not a toxic amount of energy, to slow down protein catabolism in critically ill patients. Amino acid supplementation is given to patients in case of insufficient amino acid intake in healthy individuals and specific physiological or pathophysiological situations. The amino acid requirement is lower in parenterally-fed infants and children than in enterally-fed infants because the supply bypasses the intestine.

Parenteral Nutrition Market, by Nutrient Type – 2022 and 2030

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

In terms of end user, the parenteral nutrition market is categorized into hospitals, clinics, and others. The hospitals segment held the largest share of the market in 2022; however, the clinic segment is anticipated to register the highest CAGR in the parenteral nutrition market during 2022-2030. Hospitals are considered the largest entities that have all the facilities available. Hospitals also provide various diagnostics and treatment facilities that can be reimbursed under insurance claims. Hospitals are associated with various doctors, specialists’ doctors, and other professionals who provide enhanced healthcare services. All types of cardiovascular diseases can be treated in hospitals. Hospitals serve a substantial role by providing extensive medical services, including nursing services, to patients suffering from a variety of diseases. This increased the adoption of transdermal drug delivery systems for several diseases and surgeries among patients in hospitals.

Regional Analysis:

The scope of the parenteral nutrition market report is primarily divided into North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

In 2022, in terms of revenue, North America dominated the parenteral nutrition market share. The US holds the largest market share in the region. Cancer, heart disease, and other chronic diseases are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country are diagnosed with at least one chronic disease. Additionally, the American Hospital Association estimates that ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030. According to an article titled “Trends in Parenteral Nutrition,” published in January 2019; on average, ~34,000 patients receive parenteral nutrition (PN) annually in the US. Enteral tube feeding can be prescribed for treating more than 350 diseases and medical conditions in children.

The US parenteral nutrition market growth is further fueled by government initiatives for making people aware of enteral and parenteral nutrition through awareness programs. For instance, the Feeding Tube Awareness Foundation creates awareness about the adoption of feeding tubes as a lifesaving medical intervention and helps parents of tube-fed children. The foundation celebrated the annual Feeding Tube Awareness Week from February 4, 2019, to February 8, 2019.

Asia Pacific is expected to register the highest CAGR during 2022–2030. The parenteral nutrition market in Asia Pacific is expected to grow owing to the growing presence of major market players across the region and the increasing prevalence of chronic diseases. Due to these factors, the region records the highest manufacturing of parenteral nutrition products. Australia, India, South Korea, and a few other countries in the region are estimated to witness various growth opportunities due to the growing development in the healthcare sector during the forecast period. In addition, governments of these countries are increasing their efforts to provide parenteral nutrition.

Competitive Landscape and Key Companies:

The parenteral nutrition market report is focused on prominent players in the market such as ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, Vifor Pharma Management AG, and Aculife Healthcare Pvt Ltd. The parenteral nutrition market forecast can help stakeholders plan their growth strategies. These companies focus on new technologies, upgrading existing products, and geographic expansions to meet the rising consumer demand worldwide.

In December 2022, Baxter International Inc introduced the ExactaMix Pro Automated Compounder in the US. The product debuted at the beginning of 2023. The recently released product makes use of cutting-edge compounding technology to enhance patient safety, process effectiveness, and formulation accuracy.

In October 2022, B. Braun SE demonstrated its macro and micro compounder, APEX Compounding System, and its proprietary TPN Manager Clinical Decision Support Order Entry Software. In order to reduce the chance of precipitation, the TPN Manager program included Trissel's Ca/P check, which enables users to create templates to standardize their order format.

In March 2022, Fresenius Kabi AG received FDA approval for its SMOFlipid Lipid Injectable Emulsion. The injection is intended for pediatric patients, including term and preterm neonates in the US. The product is the first and only four-oil lipid emulsion for parenteral nutrition patients of every age. The SMOFlipid can be used in all facility centers.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Nutrient Type, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is parenteral nutrition?

Parenteral nutrition is a type of nutritional supplementation administered intravenously that includes fluids, vitamins, minerals, trace elements, amino acids, and electrolytes. Compared to enteral (gastric or intestinal) feeding, parenteral nutrition is more complex, more costly, and linked to a higher risk of infection and longer hospital stays. Only patients who are unable to receive nutrition enterally are prescribed parenteral nutrition. The goals of parenteral nutrition therapy include restoring nutritional status, treating hypoproteinemia, fixing muscle weakness, and replacing other nutritional deficits.

What are the driving factors for the parenteral nutrition market across the globe?

The factors that are driving growth of the market are the rise in prevalence of gastrointestinal diseases and surge in cases of malnutrition and premature births.

Who are the major players in the parenteral nutrition market?

The parenteral nutrition market majorly consists of the players such as ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, Vifor Pharma Management AG, and Aculife Healthcare Pvt Ltd. among others.

Which country is dominated the parenteral nutrition market?

US holds the largest market share in parenteral nutrition market. Cancer, heart disease, and other chronic diseases are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country are diagnosed with at least one chronic disease. Additionally, the American Hospital Association estimates that ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030.

Which nutrient type segment is dominating the parenteral nutrition market?

The parenteral nutrition market, based on nutrient type, is segmented into rbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamins and minerals. The parenteral nutrition market analysis estimated that the single dose amino acid solution segment held the largest share of the market in 2022; and the parenteral lipid emulsion segment is likely to register the highest CAGR in the parenteral nutrition market during 2022–2030.

Which end user segment is dominating the parenteral nutrition market?

The parenteral nutrition market by end user is categorized into hospitals, clinics, and others. The hospitals segment anticipated to hold a significant parenteral nutrition market share by 2030; however, the clinic segment likely to register the highest CAGR in the parenteral nutrition market during 2022–2030.

Which region is the fastest growing the parenteral nutrition market?

Asia Pacific is expected to be the fastest growing region in the parenteral nutrition market. The parenteral nutrition market in Asia Pacific is expected to grow owing to the growing presence of major market players across the region and the increasing prevalence of chronic diseases. Due to these factors, the region records the highest manufacturing of parenteral nutrition products. Australia, India, South Korea, and a few other countries in the region are estimated to witness various growth opportunities due to the growing development in the healthcare sector during the forecast period.

The List of Companies - Parenteral Nutrition Market

  1. ICU Medical Inc   
  2. Grifols SA               
  3. Pfizer Inc                
  4. Otsuka Pharmaceuticals Co Ltd
  5. Baxter International Inc   
  6. B Braun SE             
  7. Fresenius Kabi AG              
  8. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd  
  9. Vifor Pharma Management AG
  10. Aculife Healthcare Pvt Ltd            

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Parenteral Nutrition Market